LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Company News/Rothman Orthopaedics Partners With NueHealth and MUVE Health
Company News

Rothman Orthopaedics Partners With NueHealth and MUVE Health

February 25, 2019 2 min read Premium comments

Advertisement

Rothman Orthopaedics Partners With NueHealth and MUVE Health
Courtesy of Rothman Orthopaedics, NueHealth and MUVE Health
#rothmanorthopaedicsSecondary#alexandervaccaro#muvehealth#nuehealth

Philadelphia-based Rothman Orthopaedics Institute, one of the country’s largest orthopedic practices, has announced a partnership with Leawood, Kansas-based NueHealth, an Ambulatory Surgical Platform company, and Denver, Colorado-based MUVE Health, a developer and operator of total joint and spine centers.

The companies plan to integrate their models and platforms, expanding and scaling the success that they have had together in the Greater Philadelphia market. The partnership will focus on expanding beyond the tri-state area and breaking into the orthopedic markets in Florida, Texas, and several Midwest states.

Alexander R. Vaccaro, M.D., Ph.D., MBA, president of Rothman Orthopaedic Institute, told OTW, “NueHealth has over 20-years’ experience developing, managing, and owning surgical facilities (surgery centers/specialty hospitals) throughout the United States. They currently manage/own over 50 facilities, including five surgery centers and two specialty hospitals with Rothman Orthopaedics in the Philadelphia and South Jersey areas. They have done an outstanding job over the years and this is why we are expanding our relationship through a national joint venture with their MUVE Centers.”

Dan Tasset, CEO of NueHealth, said, “We are very excited about the commitment of our Rothman partners to expand our platform integration and to scale the unprecedented clinical and economic success we have had together in the Greater Philadelphia market into new areas of the country.”

“Orthopaedics is leading the transition from fee-for-service care to value-based care and Total Hip and Knee Arthroplasty being delivered in tech-enabled, clinically integrated and purpose-built facilities like our MUVE Health centers is what the consumer, payor and employers are demanding.”

OTW spoke with John Palumbo, executive chairman of ValueHealth, the parent company of NueHealth and MUVE Health. Palumbo said, “Our partnership with Rothman Orthopaedics has changed the landscape of orthopaedic care in the Greater Philadelphia market. The expansion of our partnership will bring the highest value and clinical expertise that we have experienced locally to patients and orthopaedic practices nationwide.”

“The opportunity that exists for orthopedic practices is immeasurable. We are confident that this partnership accelerates the transformation of the industry from fee for service to value-based care.”

Palumbo continued, “The new joint venture will allow for the acceleration of ValueHealth’s mission of transforming ambulatory surgical care. This national partnership will give us the flexibility and capacity to invest more meaningfully in transforming our current NueHealth orthopaedic facilities, develop more MUVE Health hyper-specialty centers in target markets and deliver on the promise of value-based care for patients, payors and employers.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy